243 related articles for article (PubMed ID: 24314536)
1. Analysis of UR-144 and its pyrolysis product in blood and their metabolites in urine.
Adamowicz P; Zuba D; Sekuła K
Forensic Sci Int; 2013 Dec; 233(1-3):320-7. PubMed ID: 24314536
[TBL] [Abstract][Full Text] [Related]
2. Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product.
Grigoryev A; Kavanagh P; Melnik A; Savchuk S; Simonov A
J Anal Toxicol; 2013 Jun; 37(5):265-76. PubMed ID: 23592743
[TBL] [Abstract][Full Text] [Related]
3. UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products.
Kavanagh P; Grigoryev A; Savchuk S; Mikhura I; Formanovsky A
Drug Test Anal; 2013 Aug; 5(8):683-92. PubMed ID: 23315949
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Synthetic Cannabinoid UR-144 on Human Psychomotor Performance--A Case Report Demonstrating Road Traffic Risks.
Adamowicz P; Lechowicz W
Traffic Inj Prev; 2015; 16(8):754-9. PubMed ID: 25794331
[TBL] [Abstract][Full Text] [Related]
5. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
Sobolevsky T; Prasolov I; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine.
Mohr AL; Ofsa B; Keil AM; Simon JR; McMullin M; Logan BK
J Anal Toxicol; 2014 Sep; 38(7):427-31. PubMed ID: 24908262
[TBL] [Abstract][Full Text] [Related]
7. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
[TBL] [Abstract][Full Text] [Related]
8. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures.
Grigoryev A; Melnik A; Savchuk S; Simonov A; Rozhanets V
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2519-26. PubMed ID: 21803006
[TBL] [Abstract][Full Text] [Related]
9. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
Hutter M; Broecker S; Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
[TBL] [Abstract][Full Text] [Related]
10. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples.
Rojek S; Korczyńska-Albert M; Kulikowska J; Kłys M
Arch Med Sadowej Kryminol; 2017; 67(2):104-120. PubMed ID: 29363897
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
[TBL] [Abstract][Full Text] [Related]
12. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
Franz F; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
[TBL] [Abstract][Full Text] [Related]
13. Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS.
Kavanagh P; Grigoryev A; Melnik A; Savchuk S; Simonov A; Rozhanets V
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 934():102-8. PubMed ID: 23917406
[TBL] [Abstract][Full Text] [Related]
14. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
15. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
[TBL] [Abstract][Full Text] [Related]
16. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
[TBL] [Abstract][Full Text] [Related]
17. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
Borg D; Tverdovsky A; Stripp R
J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
[TBL] [Abstract][Full Text] [Related]
18. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
Park M; Yeon S; Lee J; In S
J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
[TBL] [Abstract][Full Text] [Related]
19. Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.
Jang M; Kim IS; Park YN; Kim J; Han I; Baeck S; Yang W; Yoo HH
Anal Bioanal Chem; 2016 Jan; 408(2):503-16. PubMed ID: 26514671
[TBL] [Abstract][Full Text] [Related]
20. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
Ford LT; Berg JD
Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
